IC 51 in children travelling to Japanese encephalitis virus-endemic areas
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2012
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Intercell
- 01 Feb 2012 Results published in an Intercell media release.
- 18 Aug 2011 Status changed from recruiting to active, no longer recruiting, according to an Intercell media release.
- 09 Nov 2010 The trial is progressing according to plan, according to an Ixario media release. Data is expected in 2012.